Late last year, visionaries from Merck, Syneos Health and Accenture took part in a live video debate on what now influences the way life sciences companies manage Quality – and what the future holds for the discipline, including the potential to pre-empt and minimise Quality issues using AI technology. James Kelleher at Generis chaired the proceedings, which included a live audience poll.